Pharmaceutical Executive June 2, 2022
Approval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.
I’ve spent the last 25 years leading and scaling IT projects for major health plans. In that time, I’ve seen our healthcare system’s inadvertent inability to treat mental and behavioral health disorders as chronic conditions firsthand. Even with the most advanced technologies and treatment capabilities based upon proven and validated science at the ready, we are still unable to get mental and behavioral health care to the people who need it most.
Far too many people struggling with mental and behavioral health conditions are doing so outside of the healthcare system; nearly 1 in 3 are going without treatment, even in...
Today's Sponsors
Today's Sponsor